These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24563500)

  • 41. Testosterone therapy and obstructive sleep apnea: is there a real connection?
    Hanafy HM
    J Sex Med; 2007 Sep; 4(5):1241-6. PubMed ID: 17645445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of coronary artery disease in men: male hormone, female hormone, or both?
    Yang C; Wang X; Geng C; Ding H
    Med Hypotheses; 2010 Dec; 75(6):671-3. PubMed ID: 20810222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnosis and treatment of hypogonadism in adult males].
    Köhn FM
    Hautarzt; 2004 Sep; 55(9):877-895; quiz 896-7. PubMed ID: 15484339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone and the heart.
    Hackett G
    Int J Clin Pract; 2012 Jul; 66(7):648-55. PubMed ID: 22698417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process.
    Jones TH; Saad F
    Atherosclerosis; 2009 Dec; 207(2):318-27. PubMed ID: 19464009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interdisciplinary problems of male health: point of view of a cardiologist].
    Mamedov MN; Sharvadze GG; Poddubskaia EA; Didigova RT
    Kardiologiia; 2011; 51(11):91-6. PubMed ID: 22117776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 49. Men's health in primary care: an emerging paradigm of sexual function and cardiometabolic risk.
    Miner MM
    Urol Clin North Am; 2012 Feb; 39(1):1-23. PubMed ID: 22118341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The truth about testosterone replacement therapy. Fountain of youth--or harbinger of health woes?
    Johns Hopkins Med Lett Health After 50; 2014 Jun; 29(5):1-2. PubMed ID: 25097952
    [No Abstract]   [Full Text] [Related]  

  • 51. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone supplementation: what and how to give.
    Jockenhövel F
    Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of testosterone in men's health.
    Ide H
    Endocr J; 2023 Jul; 70(7):655-662. PubMed ID: 37045775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormones and cardiovascular disease in older men.
    Yeap BB; Flicker L
    J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events.
    Corona G; Rastrelli G; Maseroli E; Fralassi N; Sforza A; Forti G; Mannucci E; Maggi M
    Andrology; 2014 Sep; 2(5):741-7. PubMed ID: 25044637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review.
    Traish AM
    Sex Med Rev; 2023 Sep; 11(4):384-394. PubMed ID: 37587664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone replacement therapy for treatment refractory cluster headache.
    Stillman MJ
    Headache; 2006 Jun; 46(6):925-33. PubMed ID: 16732838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.